View
4
Download
0
Category
Preview:
Citation preview
Q2
J Pediatr Adolesc Gynecol (2009) -:-
ARTICLE IN PRESS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
Case Report 7475
76
77
78
79
80
81
82
83
84
85
86
87
88
89
OOF
Congenital Imperforate Hymen with Hydrocolpos andHydronephrosis associated with Severe Hydramnios andIncrease of Maternal Ovarian Steroidogenic Enzymes
Emmanouil Karteris1, Helen Foster1, Maria Karamouti2, and Anastasia Goumenou1,2
1Centre for Cell Chromosome Biology, Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge, UK;2University of Crete, Division of Medicine, Department of Obstetrics and Gynecology, Heraklion, Crete, Greece
C90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
RRE
Abstract. Study Objective: To study a clinical features ofpatient presented with severe hydramnios, associated withhydronephrosis, that was antenatally diagnosed and hasbeen successfully treated immediately after birth. At a mo-lecular level, we investigated the gene expression of keysteroidogenic enzymes from the maternal ovary.
Design: Ultrasound scan, MRI, semi-quantitative RT-PCRSetting: The patient was admitted to the University Hos-
pital, University of Crete, Medical School, Greece, whereall clinical data has been obtained. Gene expression studiestook place at Biosciences, Brunel University, UK.
Results: Semi-quantitative RT-PCR analyses revealedthat there is upregulation of key steroidogenic genes inthe maternal ovary, including steroidogenic acute regula-tory protein, and the cytochrome P450 heme-containingproteins CYP11A, CYP17 and CYP19. From a clinical per-spective, the prenatal ultrasound scan and MRI findingsshowed a multicystic pelvic mass, bilateral hydronephrosisand prior to delivery severe polyhydramnios.
Conclusion: This clinical case is the only one that wehave found in the current literature where congenital imper-forate hymen accompanied with hematocolpos is associatedwith renal obstruction in combination with polyhydramniosand increase in maternal steroidogenic enzymes.
O 116117
118
119
120
121
122
NCKey Words. Ovarian steroidogenic enzymes—Hydrocolpos—Polyhydramnios
123
124
125
126
127
128
129
UIntroduction
Congenital imperforate hymen is the most frequentcongenital malformation of the female genital track,
Address correspondence to: Emmanouil Karteris, PhD, Centre for
Cell Chromosome Biology, Biosciences, School of Health Sci-ences and Social Care, Brunel University, Uxbridge, UB8 3PH,
UK; E-mail: Emmanouil.karteris@brunel.ac.uk
� 2009 North American Society for Pediatric and Adolescent GynecologyPublished by Elsevier Inc.
130
131
132
133
PEDADO1098_proof �
TEDPRwhere mucus and blood from endometrial sloughing
accumulate in the vagina.1 When presented in adults,there is a distension of the vaginal canal that can leadto cervical dilation and formation of a hematometraand hematosalpinx. Symptoms in adults include cy-clic and abdominal pain, amenorrhea, and difficultywith urination.2 Retrograde menstruation, i.e., back-ward menstruation into the peritoneal cavity, can leadto the onset of endometriosis.
Endometriosis is a clinical and pathological entitythat is characterized by the presence of tissue that re-sembles functioning endometrial glands and stromaoutside the uterine cavity. Symptoms include infertil-ity and chronic pelvic pain.3 It has been hypothesizedthat vaginal secretions accumulate in response to cir-culating maternal estrogens.4 Interestingly, recentclinical and laboratory studies support the conceptthat endometriosis is an estrogen-dependent condi-tion. Indeed, high estradiol concentrations have beenidentified as a requisite for proliferation of endometri-otic lesions, and inducement of a hypoestrogenic stateis a current therapeutic approach.5
To the best of our knowledge, hydrocolpos (cysticdilatation of the vagina) as an isolated prenatal findinghas only been reported twice previously.6,7 Vaginalobstruction may be characterized by the sole presenceof an imperforate hymen, a transverse vaginal septum,or by the presence of a urogenital sinus or cloacalmalformation.8 Imperforate hymen is the result ofthe failure of canalization of the vaginal plate,1 whichis formed in part of the Mullerian ducts and from theurogenital sinus.8 A rare condition of congenital im-perforate hymen has been presented in which obstruc-tion of the vagina was associated with accumulationof uterovaginal secretions produced under circulatingmaternal estrogen stimulation, and the developmentof a hydrometrocolpos. Large hematocolpos may lead
1083-3188/09/$36.00doi:10.1016/j.jpag.2009.10.002
134
09–11–2009 23:14:21
C
2 Karteris et al: Congenital Imperforate Hymen
ARTICLE IN PRESS
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
UNCORRE
to secondary oligoamniosis, due to renal obstructionand deteriorating renal function. Interestingly, anadult case of hematocolpos was a consequence ofradiotherapy for cervix carcinoma.9 Moreover, in a re-cent study of a 15-year-old girl with imperforatehymen with hematocolpometra, the serum tumormarker CA125 was elevated.10
This particular clinical case is the only that we havefound in the current literature in which congenitalimperforate hymen accompanied with hydrocolpos isassociated with renal obstruction in combination withpolyhydramnios and increase in key steroidogeniccomponents of the maternal ovary.
Methods
Ovarian SamplesThe sample used in this clinical case was obtainedduring cesarean section surgery, due to the presenceof a cyst. Therefore, apart from the cyst, an ovarianbiopsy was also obtained from surface to clarify thenature of the cyst. The ovarian biopsy was taken withscissors and there was no significant bleeding. Allcontrol women were age matched, undergoing cesar-ean section, and there was a presence of ovarian cysts.For this study, maternal informed consent was ob-tained after the procedure was fully explained. Allprocedures followed were in accordance with the eth-ical standards of the responsible institutional commit-tee on human experimentation. Ovarian samples(n 5 4; 1 from the clinical case and 3 pooled controls)were placed in RNAlater� (Sigma Aldrich, UK) untilfurther use.
RNA Isolation and cDNA SynthesisEach sample was lysed in 600 ml of RNA lysis bufferusing the TissueLyser (Qiagen, UK). Total RNA wasextracted from these specimens using an RNA extrac-tion kit (Sigma, UK), according to manufacturer’s in-structions. RNA concentration was determined byspectrophotometric analysis (NanoDrop, Thermo Sci-entific, UK). RNA (200ng) was reverse-transcribed intocDNA using 5 IU/ml RNase H reverse transcriptase(Invitrogen, UK).
Semiquantitative RT-PCRPCR amplification was carried out using Taq poly-merase (Invitrogen). The primers used for thisstudy were: steroidogenic acute regulatory protein(StAR, 181 bp): 5’-CGTGACTTTGTGAGCG-3’ and5’-GCCACGTAAGTTTGGT-3’; CYP11A (202 bp):5’-AGAGTTGAAATCCAACA CC-3’ and 5’-TGGGACAGACGACTGA-3’; CYP17 (205 bp): 5’-GTGACCGTAA CCGTCT-3’ and 5’- ATGAACTGATCCGGCT-3’; HSD3B2 (298 bp): 5’-CCATACCCGTA-CAGCA-3’and 5’-AT TGACCTCGGACACT-3’;
PEDADO1098_pr
TEDPROOF
CYP19 (242 bp) 5’-CAGAGGCCAAGAGTTTGAGG-3’ and 5’-ACACTAGCAGGTGGGTTTGG-3’;b-actin (216 bp): 5’-AAGAGAGGCATCCTCACCCT-3’ and 5’-TACATGGCTGG GGTGTTGAA-3’.After an initial denaturation step of 94�C for 4 min,28 cycles were performed consisting of an initial de-naturing step at 94�C for 30s, followed by extensionat 60�C for 30 s and elongation at 72�C for 1 min.Densitometric analysis of resulted PCR products re-solved on a 2% agarose gel were quantified usingthe AlphaEase FC software.
Results
Molecular Findings—Changes in the GeneExpression of Steroidogenic Components in theMaternal OvaryAs mentioned previously, it has been hypothesizedthat vaginal secretions accumulate in response to cir-culating maternal estrogens.4 In this study we alsosought to investigate this hypothesis by assessingthe gene expression of key steroidogenic enzymesfrom the maternal ovary compared to age-matchedpooled controls. Semi-quantitative RT-PCR revealedsignificant upregulation of the following genes whencompared to an age-matched normal ovary: StARby 1.55, CYP11A by 1.67, CYP17 by 7.1 andCYP19 by 5.2 fold (Fig 1). The most profound in-crease was that of CYP17 and CYP19 when comparedto the normal ovary, whereas the levels of 3bHSD2 re-mained unaltered (data not shown). This is the firststudy that we have found to describe a fetus withhydrocolpos exhibiting changes in the expression ofmaternal steroidogenic enzymes at the ovarian level.
Clinical Findings—Identification of Cystic Massand Hydronephrosis Using Ultrasound Scan andSurgical ProceduresAn abdominal cystic mass with maximum diameter43.5� 29.4 mm was discovered on a prenatal sono-gram in a female fetus at 29 weeks gestation ina 32-year-old woman para 1, gravida 3. Fetal biome-try was within the normal range for gestational age.The patient’s prenatal course, which included amnio-paracentesis (because of patient’s family history fortrisomy 21 in a maternal aunt) had been uncompli-cated and previous ultrasound scan examinations aswell as 21 weeks ultrasound scan were reported nor-mal. Cytogenetic analysis revealed a normal femalekaryotype (46 XX), and no chromosomal abnormali-ties were detected. There was no history of familialimperforate hymen. All serial prenatal ultrasoundscans were performed at a specialist fetal medicineunit. On follow-up scans every 5e10 days, the ap-pearance of the pelvic cystic mass showed a gradualenlargement (Fig 2, panels a, b) and mild bilateral
oof � 09–11–2009 23:14:21
UNCORRECTEDPROOF
StAR
CYP11A
CYP17A
CYP19A
ββ-actin
1 2 3
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Normal
ae
rci
dlo
Fs
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
ae
rc
ni
dl
oF
s
0
1
2
3
4
5
6
7
8
ae
rc
ni
dl
oF
s
0
1
2
3
4
5
6
ae
rc
nidl
oF
s
0
1
2
3
es
ae
rc
ni
dl
oF
Patient
Normal Patient
Normal Patient
Normal Patient
Normal Patient
Fig. 1. Changes in the gene expression of steroidogenic components in the maternal ovary. Lane 1: cDNA from normal ovaries;Lane 2: cDNA from patient; Lane 3: negative control.
Q13Karteris et al: Congenital Imperforate Hymen
ARTICLE IN PRESS
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
PEDADO1098_proof � 09–11–2009 23:14:21
NCORREC
OF
web
4C=F
PO
Fig. 2. Panel a: Longitudinal view of the large cystic ab-dominal mass with gravity dependent echoes, extendingup to the diaphragm at 33� 5 weeks gestation. Panel b:Transverse view at 33� 5 weeks gestation reveals a largecystic abdominal mass. Panel c: Sagittal view of bilateralhydronephrosis, at 33� 5 weeks gestation
web
4C=F
PO
Fig. 3. A view of surgical hymenotomy performed by pedi-atric surgeons.
4 Karteris et al: Congenital Imperforate Hymen
ARTICLE IN PRESS
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
Uhydronephrosis (Fig 2, panel c), but there were nochanges in amniotic fluid volume.
The patient was admitted to the hospital at 32weeks because of premature uterine contractions andcorticosteroids were administered to prepare for even-tual preterm birth as well as tocolytic therapy intrave-nously (IV) to control contractions. At 35 weeks ofgestation the size of cystic mass increased, measuring86� 75 mm maximum and hydronephorsis worsened.
PEDADO1098_pr
TEDPROUreteronephrosis was noticed while amniotic fluid
volume significantly increased (amniotic fluid index(AFI) was 25e27 cm) followed by hydramniosdevelopment. The estimated fetal weight was 3150 g.
Due to premature contractions and a history of pre-vious cesarean section, the patient underwent anemergency cesarean section and a female neonateweighting 3250 g, at 35 weeks of pregnancy, with Ap-gar scores of 8 and 9 after 1 and 5 minutes, respec-tively, was delivered. The neonate was admitted tothe neonatal intensive care unit for ventilatory supportand further investigations. Physical examinationshowed soft but distended mass above the umbilicusabdomen measuring 8� 7 cm.
Bladder catheterization was performed withdifficulty and clear urine was expressed. Renal func-tion tests were normal at birth, with a creatinine of0.7 mmol/L, and urea at 24 mmol/L. Abdominal ultra-sound examination showed a cystic mass posterior tothe bladder, bilateral hydronephrosis (1.3 cm) andhydroureter. MRI revealed an abdominal cystic masswith maximal diameter 90� 70 mm, which was feltto be a hydrometrocolpos due to an imperforatehymen.
Additional investigation of the urinary system dem-onstrated normal kidneys, renal calyces, ureter, anda small bladder displaced to the anterior abdominal walldue to the mass effect of the hydrocolpos. Neither refluxnor ureteroceles were observed. The patient was re-ferred to pediatric surgery. Consent was obtained fromthe baby’s parents, and a hymenectomy was performedwhere approximately 200 mL of clear serous andmucoid fluid was drained (Figs 3 and 4).
Discussion
Congenital imperforate hymen is the most frequentobstructive anomaly of the female genital tract. Thisgenerally occurs sporadically, with a reported
oof � 09–11–2009 23:14:21
C
Q3
4web
4C=F
PO
Fig. 4. View of tubing for drainage of retained secretionstrough vagina.
web
4C=F
PO
5Karteris et al: Congenital Imperforate Hymen
ARTICLE IN PRESS
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
Eincidence at term11 of 0.014e1% and gives rise to hy-drometrocolpos in less than 1/16000 female births.12
Failure of this membrane to rupture results in congen-ital imperforate hymen, which in combination withaccumulation of uterovaginal secretions, (producedas a consequence of intrauterine stimulation of cervi-cal mucous glands by maternal estrogen hormones),may lead to the development of an internal hydrome-trocolpos.13 This can be presented as a pelvic mass incombination or not with urinary track obstruction andoligohydramnios.
In this clinical case the cystic mass presented for thefirst time during the 3rd trimester (29 weeks of gesta-tion), having hypoechoic content with a maximumdiameter of 43.5� 29.4 mm. At 35 weeks the cysticmass had a maximum diameter of 86� 75 mm causingbilateral urinary obstruction and hydronephrosis. What
UNCORR
Fig. 5. Diagrammatic representation of steroid hormone biosynthethat have been upregulated in the maternal ovary of the fetus wi
PEDADO1098_proof �
TEDPROOF
is interesting and unique in our case is the fact thatalthough there was a lack of a normal urinary outlet,oligohydramnios was not found. On the contrary, anevident increase of the amniotic fluid volume (AFI,25e27 cm) was observed. Cianciosi et al suggestedthe following mechanisms for accompanied hydram-nios in abdominal cystic masses: (a) the compressionof the adjacent bowel by the expanding cyst causinga hypoperistaltic intestine, or reduction of the absorp-tive capacity of the stomach and bowel by modifyingthe gastrointestinal vascularization, and (b) the depres-sion Qor an incorrect swallowing process, as suggestedby tongue protrusion, reducing the fluid removal fromthe amniotic cavity.14
The differential diagnosis of imperforate hymen isfrom labial adhesions, vaginal atresia, vaginal agene-sis, and transverse vaginal septum. However, the ab-dominal mass has to be diagnosed differentiallyfrom distental urinary bladder, ovarian tumors andneoplasms, mesenteric cysts, anterior meningoceles,reduplication of sigmoid and sacral tumors. Prenatalultrasonographic diagnosis of hydrocolpos has onlybeen reported in three cases,7,15,16 none of whichhad hydramnios detected.
As mentioned previously, it has been hypothesizedthat vaginal secretions accumulate in response tocirculating maternal estrogens.4 Therefore, based onour observations from the gene expression studies, itis attractive to speculate that, in this particular clinicalcase of hydrocolpos, the overall steroidogenic activityin the maternal ovary would have been enhanced. In-deed, when compared to control patients, the largestincrease in gene expression was that of CYP17 andCYP19. CYP17 is expressed in all classic steroido-genic organs and in the human ovary it is selectively
Q5sis steps in the human ovary. In red Q6are the key componentsth hydrocolpos.
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
09–11–2009 23:14:22
C
6 Karteris et al: Congenital Imperforate Hymen
ARTICLE IN PRESS
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
ORREexpressed in thecal cells.17 CYP19, on the other hand,has a far wider distribution and in the human ovary isprimarily expressed in the corpus luteum. This is ofparticular importance to this case because CYP19catalyzes reactions leading to estrogen biosynthesis.Depending on its expression, CYP19 (P450arom)catalyzes the conversion of the C19 androgens, an-drostenedione and testosterone, to the C18 estrogens,estrone and estradiol, respectively.17
It is well known that steroids such as maternalestrogens as well as progesterone rise exponentiallyduring the later stages in pregnancy. What is interestingin this clinical case is that the control ovarian sampleswere also taken from age-matched women, undergoingcesarean section. As a result, it is the possible dysregu-lation of the maternal steroidogenic pathway in thisclinical case that might contribute to the upregulationof certain enzymes. In addition, with regard to a link be-tween types of circulating estrogens and polyhydram-nios, very little is known. However, a study by Phocaset al showed that there was a discrepancy in the estrogenlevels regarding their increase. This was due to the typepolyhydramnios, the pregnancy outcome, and thecondition of fetus at birth.18
In conclusion, this is a novel clinical case where thereis clear evidence of a maternal steroidogenic over-driveassociated with fetal hydrocolpos, thus potentially link-ing maternal ovarian steroidal stimulation with thispathophysiological condition.
Uncited Figure
Fig 5
References
1. Messina M, Severi FM, Bocchi C, et al: Voluminous perinatalpelvic mass: a case of congenital hydrometrocolpos. J MaternFetal Neonatal Med 2004; 15:135
2. Bakos O, Berglund L: Imperforate hymen and rupturedhematosalpinx: a case report with a review of the literature.J Adolesc Health 1999; 24:226
UNC
PEDADO1098_pr
TEDPROOF
3. Kobayashi H, Yamada Y, Kanayama S, et al: The role ofiron in the pathogenesis of endometriosis. GynecolEndocrinol 2009; 25:39
4. Yıldırım G, Gungorduk K, Aslan H, et al: Prenatal diagno-sis of imperforate hymen with hydrometrocolpos. ArchGynecol Obstet 2008; 278:483
5. Nothnick WB, Zhang X: Future targets in endometriosistreatment: targeting the endometriotic implant. Mini RevMed Chem 2009; 9:324
6. Adaletli I, Ozer H, Kurugoglu S, et al: Congenital imper-forate hymen with hydrocolpos diagnosed using prenatalMRI. AJR Am J Roentgenol 2007; 189:W23
7. Winderl LM, Silverman RK: Prenatal diagnosis of congenitalimperforate hymen. Obstet Gynecol 1995; 85:857
8. Rock JA, Breech LL: Surgery for anomalies of the Muller-ian ducts. In: Rock JA, Jones HW III, editors. Te Linde’sOperative Gynecology, (9th ed.). Philadelphia, LippincottWilliams & Wilkins, 2003, pp 705e749
9. Soloway MS, Rao MK, Kest L: Hematocolpos with urinarytract obstruction in an adult. J Urol 1977; 117:811
10. Kalmantis K, Koumpis C, Daskalakis G, et al: Imperforatehymen with hematocolpometra combined with elevatedCa125. Bratisl Lek Listy 2009; 110:120
11. Mor N, Merlob P, Reisner SH: Types of hymen in the new-born infant. Eur J Obstet Gynecol Reprod Biol 1986; 22:225
12. Benson CB, Doubilet PM: The fetal genitourinary system.In: Fleischer AC, editor. Sonography in Obstetrics and Gy-necology. London, Prentice-Hall International, 1996, pp 444
13. Spence HM: Congenital hydrocolpos. JAMA 1962; 180:1100
14. Cianciosi A, Mancini F, Busacchi P, et al: Increased amnioticfluid volume associated with cloacal and renal anomalies.J Ultrasound Med 2006; 25:1085
15. Davis GH, Wapner RJ, Kurtz AB, et al: Antenatal diagnosis ofhydrometrocolpos by ultrasound examination. J UltrasoundMed 1984; 3:371
16. Hill SJ, Hirsch JH: Sonographic detection of fetal hydro-metrocolpos. J Ultrasound Med 1985; 4:323
17. Payne AH, Hales DB: Overview of steroidogenic enzymesin the pathway from cholesterol to active steroid hormones.Endocr Rev 2004; 25:947
18. Phocas I, Salamalekis E, Sarandakou A, et al: Hormonal andbiochemical parameters in polyhydramnios. Eur J ObstetGynecol Reprod Biol 1987; 25:277
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
oof � 09–11–2009 23:14:22
Recommended